Human Metabolomics Institute
What's Happening
HMI Stories
Human Metabolomics Institute, Inc. (HMI) is a biomedical enterprise founded by Prof. Wei Jia, a world-leading expert in translational metabolomics research. HMI is dedicated to developing and providing innovative mass spectrometry-based molecular diagnostic solutions for precision medicine and personalized health management. The company, with offices and laboratories located in Shenzhen and Shanghai, has extensive knowledge and expertise in the development of proprietary and integrated technologies of in-vitro diagnostics, targeted metabolic phenotyping, human metabolic database, machine learning and artificial intelligence to advance the early and accurate detection of human disease phenotypes. HMI has a strong executive leadership team specializing in the cutting-edge translational metabolomics research as well as business operation and management. The company is aimed to become the global leader in clinical metabolomics to transform how diseases are predicted, prevented and managed.
喜报！绘云生物院士（专家）工作站挂牌启动
精益求精，满分通过多项NCCL室间质评
专精特新，深耕出海！绘云生物再获殊荣
筑巢引凤！绘云生物获批深圳市博士后创新实践基地
绘云医学检验实验室获CNAS实验室认可证书
绘云生物牵手博圣生物 共谱新生儿疾病筛查新未来
慢性肝病防治“智能”时代：绘云生物创新肝病诊断软件获证
猪胆酸“出圈” 再掀媒体关注新热点
HMI
Vision
To become the global leader in clinical metabolomics to transform how diseases are predicted, prevented and managed.
Products and Service
HMI Super Product
HMI offers an array of proprietary IVD kits, including those for scientific research and clinical examination, enabling China to have its own products in this respect, thereby setting up the “golden standards” for the industry with its advanced technologies. In addition, it offers innovative products like AI-enabled auxiliary software and health beverages. HMI also provides outstanding scientific research services, medical laboratory services, health management, and many other services with an advanced management system and high-level quality standards.
Diagnostic Kit
Clinical test kits and chronic disease screening test kits, exclusively developed by HMI, include the one for precise screening of various chronic diseases, offering quantitative analysis targeting hundreds of small-molecule metabolites in a single assessment, a noninvasive rapid test kit for fibrosis and cirrhosis of liver, and risk screening test kits for diabetes, fatty liver, cardiovascular disease, biliary atresia, birth defects, etc.
Medical Examination
Huiyun Medical Laboratory is supported by an experienced technical team, robust scientific research strength, advanced mass spectrometry equipment, and a standardized quality management system. It offers clinical and metabolomics-based testing services through a mass spectrometry platform.
AI Diagnostic Software
HMI has developed AI-enabled auxiliary software options and integrated Internet-based tools, by combining advanced machine learning algorithms with large-scale clinical sample-based data. With these options and tools, HMI is making the early screening of diseases like chronic liver diseases more convenient and efficient on a large-scale basis.
